Lanzhou University

HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

Retrieved on: 
Friday, March 22, 2024
Week, New Drug Application, Patient, Ryan Murphy, HB, HCM, Autoimmune hemolytic anemia, Safety, Phase, Anemia, Lanzhou University, Pharmaceutical industry

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the registration stage of the Phase II/III clinical trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (“wAIHA”) in China.

Key Points: 
  • HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the registration stage of the Phase II/III clinical trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (“wAIHA”) in China.
  • This follows positive data from the proof-of-concept Phase II stage of the trial and subsequent consultation with the China National Medical Products Administration (“NMPA”).
  • If positive, the data from the trial may be used to support a future New Drug Application (“NDA”) filing.
  • The objective of the registration stage of the study is to confirm the safety and efficacy of sovleplenib in adult patients with wAIHA.

Countdown to the Finals of the ASC24 Student Supercomputer Challenge!

Retrieved on: 
Tuesday, April 2, 2024
Research, Apps, Applications, Technology, Oil, Gas, Software, Energy, Hardware, University, Science, Education, Peking University, Shanghai Jiao Tong University, Algorithm, Southwest Petroleum University, Shanghai University, Overalls, Student, LLM, Huachung University, ASC, Water, University of Erlangen–Nuremberg, Lanzhou University, Chinese, National university

The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.

Key Points: 
  • The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.
  • Alongside the primary challenges, the finals will include a Group Competition aimed at fostering cross-team collaboration among students.
  • Numerous new teams are set to join the finals, with Shanghai University, Lanzhou University, and Southern University of Science and Technology among them.
  • The enthusiasm of these new contenders promises to elevate the competition, ensuring an intense battle until the very end.

GYLD China Tour: Inviting International Youth to Explore Anhui's Remarkable Cultural Wonders and Scientific Advancements

Retrieved on: 
Wednesday, November 15, 2023
School, Carbon, Research, Information, City, Lanzhou University, Beauty, Intangibles, China Tour, Experimental Advanced Superconducting Tokamak, Science, Culture, Intangible cultural heritage, Outline of physical science, Exhibition, Guest, NIO, Management, Tourism

Anhui's relentless pursuit of scientific and technological innovations has unveiled captivating wonders.

Key Points: 
  • Anhui's relentless pursuit of scientific and technological innovations has unveiled captivating wonders.
  • On the "Science Island" in Hefei, an enormous "jar" with a five-star red flag on top of it caught the attention of these international young individuals.
  • The event was co-hosted by the Academy of Contemporary China and World Studies and the Information Office of Anhui Provincial People's Government.
  • As a dedicated exchange initiative organized within the Global Young Leaders Dialogue program, the GYLD China Tour seeks to foster a profound understanding of China by inviting young individuals from all over the world to explore diverse parts of the country.

Peking University and the Chinese University of Hong Kong Triumph at 10th ASC Finals, Claiming Top Prizes

Retrieved on: 
Thursday, May 18, 2023
Electronic Design Automation, Education, Consumer Electronics, Technology, Software, University, Hardware, Lanzhou University, Zhejiang University, Oak Ridge National Laboratory, USTC, ASC, Turing Award, Qilu University of Technology, Kasetsart University, Shanghai Jiao Tong University, HPL, University of Science and Technology of China, National Tsing Hua University, Chinese University of Hong Kong, Cloud computing, High, Running, Chinese, Champion, HPC, Peking University, Engineering, Qinghai University, Southern University of Science and Technology, FLOPS, AI, HPCG, National Academy of Engineering, AWS, FVCOM, Film industry, Video game

The 10th ASC Student Supercomputer Challenge (ASC) Finals recently concluded at the University of Science and Technology of China (USTC) in Hefei.

Key Points: 
  • The 10th ASC Student Supercomputer Challenge (ASC) Finals recently concluded at the University of Science and Technology of China (USTC) in Hefei.
  • In the virtual competition, the team from the Chinese University of Hong Kong emerged as the champion, while the teams from the Chinese University of Hong Kong, National Tsing Hua University, and Kasetsart University were recognized with the Application Innovation Award.
  • Over 300 teams from universities worldwide participated in the 10th ASC Student Supercomputer Challenge.
  • A collaborative effort by the Southern University of Science and Technology, Lanzhou University, Shanghai Jiao Tong University, Qilu University of Technology, and the Chinese University of Hong Kong resulted in efficient optimization of random quantum circuit sampling simulation.

Countdown to the 10th ASC Student Supercomputer Challenge Finals!

Retrieved on: 
Monday, April 24, 2023
Electronic Design Automation, Education, Consumer Electronics, Technology, Software, University, Hardware, Lanzhou University, ASC, Qilu University of Technology, Shanxi University, LLM, Shanghai Jiao Tong University, 2021 Trampoline Gymnastics World Age Group Competitions, Intelligence, Universidad, Science, Student, Data, Zhejiang University, Machine learning, Shanghai University, HPC, Jinan University, Tsinghua University, AI, University of Science and Technology of China, Cheeloo University, Southern University of Science and Technology, Management

ASC has a commitment to guide students in solving cutting-edge scientific tasks using supercomputers and to cultivate young talent.

Key Points: 
  • ASC has a commitment to guide students in solving cutting-edge scientific tasks using supercomputers and to cultivate young talent.
  • The focus of the 10th ASC finals will be on cutting-edge scientific issues, such as LLM, AI + science, and hydrological models.
  • To succeed in this challenge, participants must have a deep understanding of DeePMD's modeling process and optimize the training process with high-performance computing.
  • There is also a lot of excitement about the debuting teams of Shanghai University and Qilu University of Technology for making their first ASC finals appearance this year.

Technology Transfer Attorney Joins Panitch Schwarze Belisario & Nadel

Retrieved on: 
Tuesday, January 24, 2023
University, Cooley LLP, Lanzhou University, IP, Intellectual property, Wang, Senior counsel, Cell biology, Cooley, Technology transfer, Genetic engineering, Private investigator

PHILADELPHIA,  Jan. 24, 2023  /PRNewswire-PRWeb/ -- Intellectual property law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Yang "Young" Wang, Ph.D. has joined the firm as an associate. An experienced technology transfer attorney with a life sciences background, Wang will focus his practice on patent procurement, IP litigation and enforcement, counseling, and licensing and monetization.

Key Points: 
  • PHILADELPHIA, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Intellectual property law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Yang "Young" Wang, Ph.D. has joined the firm as an associate.
  • An experienced technology transfer attorney with a life sciences background, Wang will focus his practice on patent procurement, IP litigation and enforcement, counseling, and licensing and monetization.
  • "We are excited to welcome Young to the firm," said Panitch Schwarze partner Martin Belisario.
  • "His experience in technology and the life sciences will be a major asset to our clients.

HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

Retrieved on: 
Monday, October 10, 2022
LinkedIn, U.S. Securities and Exchange Commission, Lymphoma, Lanzhou University, FCR, Prevalence, Hospital, Macrophage, AIHA, Degenerative disease, Protocol, Waiha, Antibody, Patient, RBC, Stock exchange, AIM, Cancer, Private Securities Litigation Reform Act, HB, Anemia, Phagocytosis, HCM, Phosphorylation, Shanghai Stock Exchange, FC, Incidence, Adult, Safety, GLOBE, Week, Phase, Forward-looking statement, Lymphoid leukemia, COVID-19, Autoimmune hemolytic anemia, B cell, Pharmaceutical industry, Vaccine, Tyrosine-protein kinase SYK

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 10, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase II/III trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (wAIHA) in China.

Key Points: 
  • HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 10, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase II/III trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (wAIHA) in China.
  • The Phase II stage of the study is to evaluate the safety and preliminary efficacy of sovleplenib in adult patients with wAIHA.
  • If results of the Phase II stage are positive, the Phase III stage will be initiated to confirm such efficacy and safety.
  • Sovleplenib is a novel, investigational, selective small molecule inhibitor for oral administration targeting the spleen tyrosine kinase, also known as Syk.

Global Times: SCO expands membership and intl appeal as President Xi outlines priorities of solidarity, shared benefits

Retrieved on: 
Sunday, September 18, 2022
Institute, Xi, Research institute, UN, American Institute of Afghanistan Studies, Terrorism, Global Times, United Nations Security Council, Center, Lanzhou University, Social science, Center for Financial Studies, Hope, Speech, Shanghai Cooperation Organization Military Tattoo, Global, New Silk Road Initiative, Partnership, Renmin University of China, Climate change, Shanghai Cooperation Organisation, Central Asian studies, Belt, Weapon, Institute of Russian Realist Art, SCO, Chinese Academy of Sciences, Food security, Northeast Project of the Chinese Academy of Social Sciences, Foreign Policy and Security Research Center, UN Security Council Sanctions Committee on North Korea, Research, Council, Oil

The SCO represents an ideal international relationship that countries have long desired, said experts.

Key Points: 
  • The SCO represents an ideal international relationship that countries have long desired, said experts.
  • President Xi on Friday attended the restricted session of the 22nd meeting of the Council of Heads of State of the SCO.
  • The Shanghai Spirit upheld by the SCO members could also be applied in dealing with international issues, Zhu said.
  • On Friday, a memorandum of obligations on Iran's SCO membership was signed, and the SCO members began a process to admit Belarus to the SCO.

The 2021 Annual International Forum on Higher Education Was Held at Sun Yat-sen University

Retrieved on: 
Thursday, July 7, 2022
Education, Other Education, University, People, South China University of Technology, CPC, Medical education, Nanjing University, Beihang University, Xiamen University, Social Science Research, University, Sun Yat-sen University, Ministry, Huachung University, Tsinghua University, Peking University, Politics, Association, The Enrollment Management Association, Sun, Kropyvnytskyi Region Universal Research Library, United Association for Labor Education, United Kingdom, Speech, Learning, Chinese People's Political Consultative Conference, Zhejiang University, Tianjin University, Huazhong University of Science and Technology, Lanzhou University, Vice, List of education ministries, Conference, Medicine, Management, Technology, Education

On June 26, the 2021 Annual International Forum on Higher Education, was held at Sun Yat-sen University in Guangzhou both online and offline, with the theme of "Building Quality Higher Education Systems".

Key Points: 
  • On June 26, the 2021 Annual International Forum on Higher Education, was held at Sun Yat-sen University in Guangzhou both online and offline, with the theme of "Building Quality Higher Education Systems".
  • This year's forum also set up three parallel forums of "University Presidents Forum", "Scholars Forum" and "Doctoral Candidates Forum".
  • Supporting and leading national modernization with the modernization of higher education has become the main theme of high-quality development of higher education.
  • To build such a higher education system, we have to start from improving the following eight systems: collaborative education system, talent training system, disciplinary specialization system, teachers' professional development system, school classification system, education evaluation system, education opening-up system, and internal governance system.

LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

Retrieved on: 
Wednesday, May 4, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Clinical Trials, National Renewable Energy Laboratory, University of Colorado Denver Business School, Investment, Renewable energy, Partnership, Immune system, University, BS, Company, NYSE, MS, Electrical engineering, Lucent, Â, Doctor of Philosophy, Bell Labs, Ewing Marion Kauffman Foundation, Lanzhou University, HIV, Cancer, CD40, Motor vehicle, Efficiency, Antigen, Public health, HPV, B cell, Infection, Technology, Research, Growth, Entrepreneurship, Computer, Pharmaceutical industry, Vaccine, Physics, Electricity, COVID-19

LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member.

Key Points: 
  • LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member.
  • As we enter the clinical stages of a number of drug candidates (HPV, Covid) resulting from our innovative vaccine platform, I am delighted to welcome Dr. Jiong Ma as an addition to our board.
  • It is an honor to be joining the LinKinVax board, states Dr. Jiong Ma.
  • Dr. Jiong Ma brings over 25 years of experience in investing, building, and scaling technology companies.